OTLC

Oncotelic Therapeutics, Inc.

USD

Set alert

Price alert · OTLC

All alert types
0.02 USD 0.00 0.00%
As of Oct 30, 2026
0.0165 Day range 0.025
0.0165 52-week range 0.11
YTD
-75.00%
1 year
-80.00%
Open
0.0185
Prev close
0.02
Mkt cap
9.15M
Vol
175.69K
Avg vol
332.01K
EPS
0.54
P/E
0.04
More statistics
Low
0.0165
High
0.025
Earnings
Aug 18, 2023

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for OTLC has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

3.74 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A+4 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 4
  • P/B 5

Valuation

P/E 0.1×
FY 2016: -0.7×FY 2017: -0.3×FY 2018: -1.1×FY 2019: -1.4×FY 2020: -1.7×FY 2021: -4.5×FY 2022: 1.0×FY 2023: -1.9×FY 2024: -3.1×FY 2025: 0.1×
FY 2016 5y median -1.9× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: -39818×FY 2018: -29801×FY 2019: 0.0×FY 2020: 11.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 216×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.1×
FY 2016: 0.8×FY 2017: -8.3×FY 2018: -8.2×FY 2019: 0.6×FY 2020: 1.6×FY 2021: 6.5×FY 2022: 0.9×FY 2023: 1.2×FY 2024: 1.7×FY 2025: 0.1×
FY 2016 5y median 1.2× FY 2025
P/FCF -23.9×
FY 2016: -0.6×FY 2017: -0.4×FY 2018: -1.0×FY 2019: -4.5×FY 2020: -6.9×FY 2021: -11.6×FY 2022: -11.9×FY 2023: -11.5×FY 2024: -19.1×FY 2025: -23.9×
FY 2016 5y median -11.9× FY 2025
EV/EBITDA 0.1×
FY 2016: -0.4×FY 2017: -0.2×FY 2018: -3.5×FY 2019: -2.0×FY 2020: -3.2×FY 2021: -6.6×FY 2022: -5.1×FY 2023: -4.0×FY 2024: -7.1×FY 2025: 0.1×
FY 2016 5y median -5.1× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: -28668×FY 2018: -23511×FY 2019: 0.0×FY 2020: 14.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 394×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -4.2%
FY 2016: -159.5%FY 2017: -274.6%FY 2018: -95.4%FY 2019: -22.4%FY 2020: -14.5%FY 2021: -8.6%FY 2022: -8.4%FY 2023: -8.7%FY 2024: -5.2%FY 2025: -4.2%
FY 2016 5y median -8.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 9100.0%FY 2018: 34289.0%FY 2019: 0.0%FY 2020: 100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 13842000.0%FY 2018: 3002000.0%FY 2019: 0.0%FY 2020: -435.7%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -9497.2%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 13812000.0%FY 2018: 2737000.0%FY 2019: 0.0%FY 2020: -660.6%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -11290.1%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 94.9%
FY 2016: -109.2%FY 2017: 2895.6%FY 2018: 756.1%FY 2019: -43.7%FY 2020: -97.7%FY 2021: -143.2%FY 2022: 91.8%FY 2023: -65.2%FY 2024: -54824.7%FY 2025: 94.9%
FY 2016 5y median -65.2% FY 2025
ROIC -0.6%
FY 2016: -109.2%FY 2017: 2895.6%FY 2018: -113.8%FY 2019: -24.1%FY 2020: -42.3%FY 2021: -53.2%FY 2022: -31.9%FY 2023: -27.5%FY 2024: -17388.3%FY 2025: -0.6%
FY 2016 5y median -31.9% FY 2025
ROA 63.4%
FY 2016: -96.7%FY 2017: -1178.5%FY 2018: -342.6%FY 2019: -31.2%FY 2020: -48.6%FY 2021: -48.3%FY 2022: 49.3%FY 2023: -26.3%FY 2024: -16957.9%FY 2025: 63.4%
FY 2016 5y median -26.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 100.0%FY 2020: 0.0%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 99.9%
FY 2016: -0.6%FY 2017: -0.6%FY 2018: 78.3%FY 2019: -43.6%FY 2020: -75.9%FY 2021: -20.3%FY 2022: -6.5%FY 2023: 31.6%FY 2024: -53690.7%FY 2025: 99.9%
FY 2016 FY 2025
EPS (diluted) 5367.9%
FY 2016: 5.6%FY 2017: -2.0%FY 2018: 85.9%FY 2019: -63.3%FY 2020: -8.3%FY 2021: 71.1%FY 2022: 203.7%FY 2023: -151.3%FY 2024: 44.0%FY 2025: 5367.9%
FY 2016 FY 2025
Free Cash Flow -86.8%
FY 2016: -27.6%FY 2017: 28.3%FY 2018: 74.0%FY 2019: 19.8%FY 2020: -23.3%FY 2021: -57.7%FY 2022: 67.2%FY 2023: 9.1%FY 2024: 44.0%FY 2025: -86.8%
FY 2016 FY 2025

Financial Health

Current Ratio 0.1×
FY 2016: 8.7×FY 2017: 0.7×FY 2018: 0.7×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.0× FY 2025
Quick Ratio 0.1×
FY 2016: 8.7×FY 2017: 0.7×FY 2018: 0.7×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.0× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.5×FY 2021: 1.1×FY 2022: 0.6×FY 2023: 1.0×FY 2024: 1.6×FY 2025: 0.1×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA 0.0×
FY 2016: 0.3×FY 2017: 0.1×FY 2018: 0.9×FY 2019: -0.2×FY 2020: -0.7×FY 2021: -0.9×FY 2022: -2.0×FY 2023: -1.8×FY 2024: -3.4×FY 2025: 0.0×
FY 2016 5y median -1.8× FY 2025
Interest Coverage -3.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -5.8×FY 2020: -3.8×FY 2021: -4.6×FY 2022: -3.3×FY 2023: -6.4×FY 2024: -4169×FY 2025: -3.6×
FY 2016 5y median -4.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31